Revenue: As of FY2026 Q3, the actual value is USD 150.53 M, beating the estimate of USD 148.38 M.EPS: As of FY2026 Q3, the actual value is USD 0.6, beating the estimate of USD 0.56.EBIT: As of FY2026 Q3, the actual value is USD 17.05 M.<h3>Segment Revenue</h3><ul><li>Net Sales: $150.5 million for the thirteen weeks ended November 1, 2025, compared to $151.3 million for the thirteen weeks ended November 2, 2024. $458.1 million for the thirty-nine weeks ended November 1, 2025, compared to $468.0 million for the thirty-nine weeks ended November 2, 2024.</li></ul><h3>Operational Metrics</h3><ul><li>Gross Profit: $106.7 million for the thirteen weeks ended November 1, 2025, compared to $108.0 million for the thirteen weeks ended November 2, 2024. $322.4 million for the thirty-nine weeks ended November 1, 2025, compared to $335.1 million for the thirty-nine weeks ended November 2, 2024.</li><li>Operating Income: $14.9 million for the thirteen weeks ended November 1, 2025, compared to $19.2 million for the thirteen weeks ended November 2, 2024. $50.8 million for the thirty-nine weeks ended November 1, 2025, compared to $70.6 million for the thirty-nine weeks ended November 2, 2024.</li><li>Net Income: $9.2 million for the thirteen weeks ended November 1, 2025, compared to $12.3 million for the thirteen weeks ended November 2, 2024. $31.4 million for the thirty-nine weeks ended November 1, 2025, compared to $37.2 million for the thirty-nine weeks ended November 2, 2024.</li></ul><h3>Cash Flow</h3><ul><li>Net Cash Provided by Operating Activities: $43.7 million for the thirty-nine weeks ended November 1, 2025, compared to $56.9 million for the thirty-nine weeks ended November 2, 2024.</li><li>Net Cash Used in Investing Activities: - $8.8 million for the thirty-nine weeks ended November 1, 2025, compared to - $10.0 million for the thirty-nine weeks ended November 2, 2024.</li><li>Net Cash Used in Financing Activities: - $12.4 million for the thirty-nine weeks ended November 1, 2025, compared to - $70.3 million for the thirty-nine weeks ended November 2, 2024.</li></ul><h3>Unique Metrics</h3><ul><li>Adjusted EBITDA: $24.3 million for the thirteen weeks ended November 1, 2025, compared to $26.8 million for the thirteen weeks ended November 2, 2024. $77.2 million for the thirty-nine weeks ended November 1, 2025, compared to $92.6 million for the thirty-nine weeks ended November 2, 2024.</li></ul><h3>Future Outlook and Strategy</h3><ul><li>Core Business Focus: The company plans to continue focusing on its ecommerce platform and upgrading its information systems, including the order management system, to drive growth and improve operating results.</li><li>Non-Core Business: The company has a share repurchase program authorized up to $25.0 million, with $18.0 million remaining as of November 1, 2025. The company also intends to pay quarterly cash dividends, subject to market conditions and Board discretion.</li></ul>

J Jill | 10-Q: FY2026 Q3 Revenue Beats Estimate at USD 150.53 M